Market by Drug Class, Application, and Country | Forecast 2019-2028
Triton Market Research has concluded that the North America dermatological therapeutics market would grow at a CAGR of 7.76% in the estimated years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated
in this market include:
• The United States
• Canada
The growing burden of skin-related
diseases and the increase in the elderly populace are primarily driving the
growth of the United States dermatological therapeutics market. Dermatological
disorders are among the most common health issues plaguing US nationals. Also,
atopic dermatitis, which mainly affects children, was reported by the Asthma
and Allergy Foundation of America to have affected nearly 7.3% of the adults in
the country, in 2018. And out of the total number of individuals affected, 40%
were at moderate or severe stages. Thus, the increase in cases of skin
disorders is likely to increase the adoption of dermatological treatments, and
consequently propel the dermatological therapeutics market growth in the US.
Further, it must be
noted that, aging and skin disorders are directly related. The rise in the
older population and the enhanced expenditure on dermatological treatments are
expected to push the market growth to a higher level. According to the National
Population Projections report by the US Census Bureau released in 2017,
approximately 77 million people in the country will be aged 65 years and above
by 2034. Also, the median age of the US population, which was 38 years in 2017,
is expected to rise to 43 years by 2060. With old age, people are more prone to
dermatological diseases. Hence, they are increasingly opting for treatment therapies.
This has raised the demand for dermatological therapeutics, in turn, propelling
the growth of the studied market in the United States, over the forecasting
period.
Bausch Health Companies
Inc, formerly known as Valeant Pharmaceuticals, specialty pharmaceutical
company engaged in developing and introducing new treatments. It focuses on
several therapeutic areas, including dermatology. Arazlo and Bryhali are among
its popular products in the dermatological therapeutics segment. The former is
used for treating acne vulgaris; whereas, the latter is given to patients
suffering from psoriasis, to relieve them from itching, dryness, inflammation,
etc. Bausch Health is headquartered in Quebec, Canada.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN BIOLOGICS
2.2.2. ATOPIC
DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. IMPACT
OF COVID-19 – DERMATOLOGICAL THERAPEUTICS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. MARKET
DRIVERS
2.7.1. INCREASING
BURDEN OF DERMATOLOGICAL DISEASES
2.8. MARKET
RESTRAINTS
2.8.1. GRAVE
SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS
2.9. MARKET
OPPORTUNITIES
2.9.1. RISE
IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION
2.10. MARKET
CHALLENGES
2.10.1. UNAWARENESS TOWARDS
DERMATOLOGICAL DIAGNOSIS
3. NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS
3.1. ANTI-INFECTIVES
3.2. CORTICOSTEROIDS
3.3. ANTI-ACNE
3.4. CALCINEURIN
INHIBITORS
3.5. RETINOIDS
3.6. OTHER
DRUG CLASSES
4. NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION
4.1. ALOPECIA
4.2. HERPES
4.3. PSORIASIS
4.4. ROSACEA
4.5. ATOPIC
DERMATITIS
4.6. ACNE
VULGARIS
4.7. OTHER
APPLICATIONS
5. NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1. UNITED
STATES
5.1.2. CANADA
6. COMPETITIVE
LANDSCAPE
6.1. ABBVIE
INC
6.2. ALLERGAN
6.3. ALMIRALL
6.4. AMGEN
INC
6.5. BAUSCH
HEALTH COMPANIES INC
6.6. GALDERMA
6.7. GLAXOSMITHKLINE
PLC
6.8. JOHNSON
& JOHNSON
6.9. NOVARTIS
AG
6.10. PFIZER
INC
6.11. AGI
DERMATICS
6.12. LEO
PHARMA A/S
6.13. MERCK
& CO
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: NORTH AMERICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 5: NORTH AMERICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 6: NORTH AMERICA DERMATOLOGICAL
THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
FIGURE 1: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 2: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $
BILLION)
FIGURE 3: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $
BILLION)
FIGURE 4: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)
FIGURE 5: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $
BILLION)
FIGURE 6: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)
FIGURE 7: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $
BILLION)
FIGURE 8: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)
FIGURE 9: NORTH AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)
FIGURE 10: NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $
BILLION)
FIGURE 11: NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $
BILLION)
FIGURE 12: NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN
$ BILLION)
FIGURE 13: NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $
BILLION)
FIGURE 14: NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028
(IN $ BILLION)
FIGURE 15: NORTH
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028
(IN %)
FIGURE 16: UNITED
STATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 17: CANADA
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)